Excess Mortality in Polycythemia Vera and Essential Thrombocythemia

Conclusion. From the population viewpoint, ET and PV do not carry an increased excess mortality until late in the second follow-up decade or later. Nevertheless, appearance of a thrombotic event significantly increases the subsequent excess mortality.Figure 1DisclosuresHernandez Boluda: Incyte: Consultancy; Novartis: Consultancy. Ferrer Marin: Novartis: Consultancy, Research Funding; Incyte: Consultancy. Gómez-Casares: Bristol-Myers Squibb: Speakers Bureau; Incyte: Speakers Bureau; Novartis: Speakers Bureau. Cervantes: Celgene: Membership on an entity's Board of Directors or advisory committees; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Hospital Clinic Barcelona: Employment.

Source: Blood - November 21, 2018 Category: Hematology Authors: Pereira, A., Besses Raebel, C., Hernandez Boluda, J. C., Ferrer Marin, F., Garcia-Hernandez, C., Gomez-Casares, M. T., Perez-Encinas, M., Noya, M.-S., Cuevas, B., Caballero, G., Mata, M., Cervantes, F., Alvarez-Larran, A. Tags: 634. Myeloproliferative Syndromes: Clinical: Poster II Source Type: research